Floatz logo

Nedaplatin

Liver Metastasis of Breast Cancer

Zhejiang Cancer HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Liver Metastasis of Breast Cancer cohort.

Asset / SponsorPhaseRating
INTERFERON ALFA-2B
Roswell Park Cancer Institute
Phase 2B
Dfn-15
Roswell Park Cancer Institute
Phase 2B
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
City of Hope Medical Center
Phase 2CCC
Ipilimumab
M.D. Anderson Cancer Center
Phase 1/2CCC
Durvalumab
City of Hope Medical Center
Phase 1CCC

View all 11 →

Same molecule, other indications

Nedaplatin is also rated in:

non-small cell lung carcinomaDormant
B
Indicative ·
60 / 100
View asset →
Non-small Cell Lung CancerDormant
CCC
Indicative ·
54 / 100
View asset →
Hepatic Artery InfusionDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →